The United States Patent and Trademark Office (the “USPTO”) has launched a new program allowing qualifying Applicants to request expedited examination of their trademark applications. To qualify, the trademark application must be for a mark that will be used in association with a COVID-19 related medical product or service. Such products or services must be for the treatment and/or prevention of COVID-19. This program does not apply to products that are not subject to US FDA approval.
Read more here.